# Trigeminal Neuralgia Due to Neurovascular Conflict: A Case Report

**Authors:** Sourabh Shinde, Vidya Lohe, Swapnil Mohod, Komal V Dadgal, Unnati Shirbhate, Dhruvi Solanki

PMC · DOI: 10.7759/cureus.54347 · Cureus · 2024-02-17

## TL;DR

A 47-year-old woman with trigeminal neuralgia caused by a blood vessel pressing on a nerve was successfully treated with a drug combination and vitamins.

## Contribution

The case highlights the effectiveness of combining carbamazepine, gabapentin, and multivitamins for trigeminal neuralgia.

## Key findings

- MRI confirmed neurovascular conflict at the root entry zone of cranial nerve-V.
- Combination therapy with carbamazepine, gabapentin, and multivitamins led to complete remission in 1.5 months.
- The case supports using this treatment approach for trigeminal neuralgia.

## Abstract

A 47-year-old female patient visited the outpatient department with the complaint of “sharp shooting, radiating type of pain” on the maxillary left posterior gingiva for the last three months. The patient was advised a magnetic resonance imaging (MRI) scan which gave the radiological diagnosis of trigeminal neuralgia (TN). It also stated that the root entry zone of cranial nerve-V (CN-V) was in contact with the superior cerebellar artery and anterior inferior cerebellar artery. The patient was kept on a carbamazepine and gabapentin combination and a supportive therapy of multivitamins which brought complete remission within 1.5 months. This case report supports the combination therapy of carbamazepine and gabapentin with supportive therapy of multivitamins.

## Linked entities

- **Chemicals:** carbamazepine (PubChem CID 2554), gabapentin (PubChem CID 3446)
- **Diseases:** trigeminal neuralgia (MONDO:0008599)

## Full-text entities

- **Diseases:** TN (MESH:D014277), pain (MESH:D010146)
- **Chemicals:** gabapentin (MESH:D000077206), carbamazepine (MESH:D002220)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10948954/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10948954/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC10948954/full.md

---
Source: https://tomesphere.com/paper/PMC10948954